ArticleCancer gene therapy2007

Radioresponsive tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene therapy for malignant brain tumors.

H Tsurushima et al.PubMed ↗Publisher ↗

No numbers read from the abstract.